Search results for: 'software for clinical studi'

25 Oct 2017  |  North America  |  Market Research

Automotive Data Monetisation Pricing and Business Models

By 2025, Data Monetisation is Expected to Unravel ~$33 Billion in Opportunity for OEMs, with the Potential to Monetise $100 per Car Across 140 Unique Use Cases

Infographics

×

This study analyses the strategies, growth analysis, competitive landscape, business models, and future focus areas of OEMs, data aggregators, usage-based insurance (UBI) companies, and tier 1 suppliers. OEMs, tier 1s, insurance companies, and data aggregators must focus on data services around smart mobility, connected cars, and autonomous vehicle...

14 Jul 2017  |  North America  |  Market Research

Gamification in the Automotive Industry, Forecast to 2025

The Global Gamification Market will Reach $14.5 Billion in 2025

Infographics

×

Gamification technologies help businesses to drive sales, improve return on investment (ROI), support employee interaction, and provide high customer satisfaction, and they are preferred across major industry verticals such as healthcare and automotive. The increasing penetration of smartphones, customized services, tech-savvy customers, the growin...

12 Aug 2020  |  North America  |  Market Research

Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026

Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth

Infographics

×

The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

The skyrocketing volume of medical imaging data and need to better manage medical images is becoming imperative for healthcare providers. The collaborative HIMSS-SIIM Enterprise Imaging Workgroup de?nes enterprise imaging as “a set of strategies, initiatives, and work?ows implemented across a healthcare enterprise to consistently and optimally capt...

22 Aug 2017  |  North America  |  Market Research

Developments in Image-Guided Therapy, Forecast to 2020

A Prime Area for Multi-Modality Convergence Forming the Next Growth Segment in Medical Imaging

Infographics

×

Medical imaging and informatics research service from the Transformational Health practice highlights the evolving trends and innovations in Image-Guided Therapy (IGT). As the fields of interventional imaging, minimally-invasive interventions, and image-guided surgery (IGS) continue to mature, the next step forward in the development of advanced tr...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

The study aims to analyze and forecast the X-ray market in India, featuring analog X-ray and computed and digital radiography segments. Total India X-ray market overview, segment market analysis (for analog X-ray, computed radiography and digital radiography), market share analysis, revenue forecast from 2013 to 2020, pricing analysis for 2015, se...

Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape in this analysis. The study period is 2021 2028, with 2023 as the base year and 2024 2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and the...